Notification of Temporary Polio Vaccination within USAFRICOM Area of Responsibility

• Identification #: GENADMIN MSG 101345Z
• Date: 2/1/2017
• Type: Guidelines
• Topics: Polio | Vaccine Recommendations by AOR

Yellow Fever Vaccine Shortage and Vaccination Requirements for USAFRICOM Theater and YF Vaccination Guidance for Leisure Travel to Morocco

• Identification #: GENADMIN MSG 071429Z
• Date: 2/1/2017
• Type: Guidelines
• Topics: Yellow Fever | Vaccine Recommendations by AOR

Force Health Protection Requirements and Medical Guidance AFRICOM AOR

• Identification #: ACI 4200.09
• Date: 1/27/2017
• Type: Guidelines
• Topics: Vaccine-Preventable Diseases | Vaccine Recommendations by AOR

DHA-PI 6040.01: Implementation Guidance for the Utilization of DD Form 1380, Tactical Combat Casualty Care (TCCC) Card

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authorities of References (a) and (b), and in accordance with the guidance of References (c) through (i), provides procedures on the use of the DD Form 1380, TCCC card, June 2014, as revised from DD Form 1380, U.S. Field Medical Card, December 1991, for standardized and consistent documentation of prehospital care by the Military Departments. Use of the DD Form 1380, TCCC card, in the prehospital environment, by both medical and non-medical first responders for battle and non-battle injuries is the preferred method of documentation in accordance with Reference (d) and an approved form to document care in accordance with Reference (e).

• Identification #: N/A
• Date: 1/20/2017
• Type: DHA Procedural Instruction
• Topics: N/A

DHA IPM 17-002: Specialty Care Referral Accountability and Business Rules

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (l): Describes procedures for implementing uniform accountability and business rules for referral management and specialty care appointing. The DHA-IPM will provide clarifications to References (d) and (f). This DHA-IPM is effective immediately. It will be incorporated into a future DHA Procedural Instruction. This DHA-IPM will expire effective 12 months from the date of issue.

• Identification #: N/A
• Date: 1/19/2017
• Type: DHA Interim Procedures Memorandum
• Topics: N/A

DHA IPM 17-001: Use of Tri-Service Workflow (TSWF) Core Adult and Pediatric Forms for Screening and Documentation of Primary Care Outpatient Face-to-Face Encounters with Providers

This interim procedures memorandum describes procedures for implementing TSWF adult and pediatric core forms for screening and documenting military treatment facility (MTF) outpatient face-to-face encounters with providers in primary care in the Armed Forces Health Longitudinal Technology Application (AHLTA) system and the new Electronic Health Record, Military Health System (MHS GENESIS).

• Identification #: DHA-IPM 17-001
• Date: 1/6/2017
• Type: DHA Interim Procedures Memorandum
• Topics: N/A

DHA IPM 16-004: Sexual Assault Medical Management with Consideration of Male Service Members of the Armed Forces

This interim procedures memorandum establishes a plan to improve medical care response to victims of sexual assault so that victims receive a coordinated, compassionate, and competent approach to address both physical and behavioral healthcare needs within the Military Health System (MHS).

• Identification #: DHA-IPM 16-004
• Date: 12/23/2016
• Type: DHA Interim Procedures Memorandum
• Topics: Health Care Management of Sexual Assault/Sexual Harassment | Sexual Assault Prevention

DHA IPM 16-003: Clinical Practice Guidelines for Access to Methods of Contraception and Contraceptive Counseling

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM) establishes comprehensive standards on care with respect to methods of contraception and counseling on methods of contraception for members of the Armed Forces and all who are eligible for medical services through the Military Health System (MHS).

• Identification #: DHA-IPM 16-003
• Date: 12/20/2016
• Type: DHA Interim Procedures Memorandum
• Topics: Women's Health

DHA PI Number 6025.01: Implementing the American College of Surgeons (ACS) National Surgical Quality Improvement Program (NSQIP) across the Military Health System (MHS)

This Defense Health Agency-Procedural Instruction (DHA-PI) assigns responsibilities and establishes uniform guidelines, standards, and procedures for all DoD Medical Treatment Facilities (MTFs) providing healthcare services in the direct care system to implement the surgical quality and reporting guidelines developed by ACS NSQIP, as well as DoD procedural requirements.

• Identification #: DHA PI Number 6025.01
• Date: 12/8/2016
• Type: Instructions
• Topics: Quality, Patient Safety and Access Information for MHS Patients | Patient Satisfaction and Access | Health Outcomes | Patient Safety | Quality of Care

AF-SG3-5 Memo - Clarification of Air Force Mumps Vaccination Guidance

• Identification #: N/A
• Date: 11/30/2016
• Type: Guidelines
• Topics: Measles-Mumps-Rubella | Vaccine Recommendations by AOR

Warrior Care Month Recognition

In this memorandum, Secretary of Defense, Ash Carter recognizes November as Warrior Care Month, an important DoD-wide effort to increase awareness of programs and resources available to wounded, ill, and injured Service members, as well as their families, caregivers and others to support them.

• Identification #: N/A
• Date: 11/14/2016
• Type: Memorandums
• Topics: Warrior Care

DoDI 1300.25: Guidance for the Education and Employment Initiative (E2I) and Operation WARFIGHTER (OWF)

This instructione establishes policy, assigns responsibilities, and provides procedures for development and implementation of the DoD E2I and OWF in accordance with the authority in DoD Directive 5124.02 (Reference (a)), section 1611 of Public Law 110-181 (Reference (b)), sections 1142-1144 of title 10, United States Code (U.S.C.) (Reference (c)) and section 8111 of title 38, U.S.C. (Reference (d)).

• Identification #: DoDI 1300.25
• Date: 11/2/2016
• Type: Instructions
• Topics: N/A

DoDI 1010.04: Problematic Substance Use by DoD Personnel

This instruction reissues DoDD 1010.4 (Reference (b)) as a DoD instruction (DoDI) and implements the requirements in section 596 of Public Law 111-84 (Reference (c)); establishes policies, assigns responsibilities, and prescribes procedures for problematic alcohol and drug use prevention, identification, diagnosis, and treatment for DoD military and civilian personnel; describes the relationship between the DoD and the Department of Veterans Affairs (VA) with regard to drug and alcohol use treatment; and incorporates and cancels DoDI 1010.6 (Reference (d)) and Assistant Secretary of Defense for Health Affairs (ASD(HA)) Memorandum 97-029 (Reference (e)).

• Identification #: DoDI 1010.04
• Date: 11/2/2016
• Type: Instructions
• Topics: Substance Abuse

COMPACFLT Guidance on the Japanese Encephalitis Vaccine for U.S. Navy Personnel and TRICARE beneficiaries in the Pacific Fleet Area of Responsibility

• Identification #: N/A
• Date: 11/1/2016
• Type: Instructions
• Topics: Japanese Encephalitis | Vaccine Recommendations by AOR

DoD Retail Pricing Agreement

DoD Retail Pricing Agreement. This agreement is intended to validate acknowledgement of manufacturer responsibility to TRICARE.

• Identification #: N/A
• Date: 10/19/2016
• Type: Guidelines
• Topics: N/A